TuHURA BIOSCIENCES, INC./NV Cash and Cash Equivalents
TuHURA BIOSCIENCES, INC./NV (HURA) had Cash and Cash Equivalents of $995.98 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $995.98K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $6.30M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.62M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $2.70M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $995.98K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.30M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $3.62M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.70M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $8.51M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.22M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $12.66M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $3.02M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.91M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $6.35M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.67M 10-K · filed 2025-03-31 | $658.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $216.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.53M 10-K · filed 2024-10-07 | |
| 2023-03-31 | $3.04M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.87M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $7.08M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $11.78M 10-K · filed 2023-09-18 | |
| 2022-03-31 | $8.84M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $14.06M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $19.34M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $10.54M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $15.72M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $17.16M 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $22.60M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.39M 10-K · filed 2021-09-28 | $2.39M 10-K · filed 2020-09-18 |
| 2020-03-31 | $4.97M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $6.35M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $8.06M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $3.72M 10-K · filed 2020-09-18 | |
| 2019-03-31 | $2.15M 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $3.70M 10-Q · filed 2020-02-13 | |
| 2018-09-30 | $3.88M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $5.97M 10-Q · filed 2020-05-13 | |
| 2018-03-31 | $8.51M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $11.02M 10-Q · filed 2019-02-11 | |
| 2017-09-30 | $13.16M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $6.59M 10-K · filed 2019-09-09 | |
| 2017-03-31 | $2.10M 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $3.42M 10-Q · filed 2018-02-14 | |
| 2016-09-30 | $4.80M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $6.16M 8-K · filed 2019-06-03 | |
| 2016-03-31 | $937.36K 10-Q · filed 2017-05-12 | |
| 2015-12-31 | $1.96M 10-Q · filed 2017-02-10 | |
| 2015-09-30 | $2.80M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $1.75M 10-K · filed 2017-09-27 | |
| 2015-03-31 | $3.01M 10-Q · filed 2016-05-12 | |
| 2014-12-31 | $3.96M 10-Q · filed 2016-02-12 | |
| 2014-09-30 | $4.32M 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $4.76M 10-K · filed 2016-09-13 | |
| 2014-03-31 | $3.47M 10-Q · filed 2015-05-15 | |
| 2013-12-31 | $4.14M 10-Q · filed 2015-02-12 | |
| 2013-09-30 | $5.17M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $6.28M 10-K · filed 2015-11-16 | |
| 2013-03-31 | $7.53M 10-Q · filed 2014-05-15 | |
| 2012-12-31 | $17.78K 10-K · filed 2014-08-28 | $3.98K 10-Q · filed 2013-01-18 |
| 2012-09-30 | $55.30K 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $227.60K 10-Q · filed 2013-08-12 | $1.79K 10-Q · filed 2013-01-18 |
| 2012-03-31 | $1.98M 10-Q · filed 2013-05-15 | $2.78K 10-Q/A · filed 2012-06-05 |
| 2011-12-31 | $15.02K 10-K · filed 2014-08-28 | $805.00 10-Q · filed 2012-02-07 |
| 2011-09-30 | $6.84K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $5.70K 10-Q/A · filed 2012-06-05 | |
| 2010-12-31 | $24.38K 10-K · filed 2014-08-28 | |
| 2010-09-30 | $36.00K 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $44.56K 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |